Dr Reddys Laboratories (RDY) Deferred Taxes (2009 - 2026)

Dr Reddys Laboratories has reported Deferred Taxes for 17 years, with the latest figure at $12.4 million in Q2 2026.

• On a quarterly basis, Deferred Taxes fell 78.49% year-over-year to $12.4 million in Q2 2026; TTM through Jun 2026 was $1.5 billion, a 5964.58% increase from a year earlier, with the FY2026 full-year figure at -$1.6 billion, down 796.07% from the prior year.
• Deferred Taxes was $12.4 million for Q2 2026 at Dr Reddys Laboratories, down from $21.0 million in the prior quarter.
• The five-year high for Deferred Taxes was $1.5 billion in Q4 2025, with the low at -$23.4 million in Q3 2024.
• Average Deferred Taxes over 5 years is $105.9 million, with a median of $28.7 million recorded in 2022.
• The largest YoY upside for Deferred Taxes was 19725.0% in 2025 against a maximum downside of 201.03% in 2025.
• Over 5 years, Deferred Taxes stood at $47.2 million in 2022, then tumbled by 75.98% to $11.3 million in 2023, then plunged by 165.71% to -$7.4 million in 2024, then surged by 19725.0% to $1.5 billion in 2025, then plunged by 99.15% to $12.4 million in 2026.
• The last three Deferred Taxes figures came in at $12.4 million (Q2 2026), $21.0 million (Q1 2026), and $1.5 billion (Q4 2025), per Business Quant data.